Drugmaker Lupin has launched Lupin Diagnostics, its new diagnostics services business, in India. The company said that the new venture is part of its strategy to provide integrated healthcare in the country.  Lupin Diagnostics is a wholly owned subsidiary. As part of Lupin Diagnostics, it has established a 45,000 sq. ft National Reference Laboratory in Navi Mumbai, with world-class equipment, experienced doctors assisted by trained technologists, and stringent quality control protocols. The lab can provide a comprehensive range of diagnostic tests, including molecular diagnostics, cytogenetics, flow cytometry, microbiology, serology, histopathology and cytology, haematology, immunology, amongst others.

“Combining decades of experience and knowledge in the field of therapeutics, we aim to provide our doctors, patients and consumers with the same experience offering quality diagnostic services that are built on trust,” said Nilesh Gupta, Managing Director, Lupin.